(Q35635738)

9 August 2017

0 references

Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature (English)

1 reference

9 August 2017

1 reference

1 reference

1

Cay Anderson-Hanley

0 references

author name string

Marne L Sherman

2

1 reference

9 August 2017

Raine Riggs

3

1 reference

9 August 2017

V Bede Agocha

4

1 reference

9 August 2017

Bruce E Compas

5

1 reference

9 August 2017

language of work or name

1 reference

1 November 2003

1 reference

Journal of the International Neuropsychological Society

9 August 2017

1 reference

9 August 2017

9

1 reference

9 August 2017

7

1 reference

9 August 2017

967-982

1 reference

Using treatment interruptions to palliate the toxicity from concurrent chemoradiation for limited small cell lung cancer decreases survival and disease control

9 August 2017

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Sequelae in long-term survivors of small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: high-dose versus standard-dose chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Minimal neuropsychological sequelae following prophylactic treatment of the central nervous system in adult leukaemia and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Ten-year experience with CMF-based adjuvant chemotherapy in resectable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Cognitive function and reproductive hormones in adjuvant therapy for breast cancer: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Neuropsychology of chronic fatigue syndrome: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Cognitive effects of standard-dose chemotherapy in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Neuropsychological evaluation of patients with inoperable non-small cell lung cancer treated with combination chemotherapy or radiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Chemotherapy and cognitive defects in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Meta-analysis: recent developments in quantitative methods for literature reviews.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Practitioner review: long-term consequences of childhood cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Neuropsychological effects of cranial radiation: current knowledge and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Neuropsychological function in patients with chronic fatigue syndrome, multiple sclerosis, and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Cognitive function in postmenopausal women treated with raloxifene

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Neuropsychiatric effects of chemotherapeutic agents for cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Methylphenidate in the treatment of neurobehavioral slowing associated with cancer and cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

What do cancer patients mean when they complain of concentration and memory problems?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Neurotoxicity of commonly used antineoplastic agents (second of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Preliminary assessment of cognitive function in breast cancer patients treated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Neurotoxicity of commonly used antineoplastic agents (first of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

The cognitive effects of recombinant interleukin-2 (rIL-2) therapy: a controlled clinical trial using computerised assessments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Timing and specificity of the cognitive changes induced by interleukin-2 and interferon-alpha treatments in cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Motor and cognitive testing of bone marrow transplant patients after chemoradiotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Cognitive deficits in patients with small cell lung cancer before and after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Cognitive functioning in cancer patients: effect of previous treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Psychosocial aspects of neoplastic disease: II. Affective and cognitive effects of chemotherapy in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Cognitive dysfunction following adjuvant treatment of breast cancer: a new dose-limiting toxic effect?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Neurological and cognitive impairment in long-term survivors of small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Serial cognitive testing in cancer patients receiving chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

Psychologic and neuropsychologic impact of autologous bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

7 January 2021

Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

7 January 2021

Cisplatin-based therapy: a neurological and neuropsychological review

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

7 January 2021

Cognitive functioning and quality of life in malignant glioma patients: a review of the literature

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

7 January 2021

Cognitive function in breast cancer patients receiving adjuvant chemotherapy.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

7 January 2021

Cognitive functioning in long-term survivors of high-grade glioma

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

7 January 2021

Trading treatment toxicity for survival in locally advanced non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

7 January 2021

Psycho-oncology: psychological well-being as one component of quality of life

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

7 January 2021

Psychological problems associated with diagnosis and treatment of lymphomas. II: Prospective study.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

7 January 2021

Evaluation of the neurobehavioral functioning of patients before, during, and after bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

7 January 2021

Quality of life in patients with limited small-cell carcinoma of the lung receiving chemotherapy with or without radiation therapy, for cancer and leukemia group B.

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

7 January 2021

The psychological and psychiatric effects of rIL-2 therapy: a controlled clinical trial

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

7 January 2021

Psychiatric side effects of interferon therapy: prevalence, proposed mechanisms, and future directions

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

7 January 2021

Neuropsychologic impairment in adult bone marrow transplant candidates

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

7 January 2021

Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

7 January 2021

Physiologic and psychobehavioral research in oncology

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

7 January 2021

Detecting significant change in neuropsychological test performance: a comparison of four models

1 reference

https://api.crossref.org/works/10.1017%2FS1355617703970019

7 January 2021

10.1017/S1355617703970019

Identifiers

DOI

0 references

1 reference